Shih-Hsien Chuang

Company: HoneyBear Biosciences, Inc.

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Overcoming Challenges in Developing Dual-Payload ADCs for Enhanced Therapeutic Efficacy 5:00 pm

Exploring the potential advantages of dual-payload ADCs over conventional single-payload ADCs, particularly in overcoming secondary drug resistance Discussing strategies for selecting and optimizing payloads to achieve a balanced therapeutic profile, considering different mechanisms of action and toxicity profiles Highlighting preclinical data requirements to validate dual-payload ADCs, emphasizing the need for compelling evidence to support their…Read more

day: Scientific Program Day Two PM